Journal article
Adverse perinatal outcomes associated with antiretroviral therapy regimens: systematic review and network meta-analysis
- Abstract:
-
Objective: Assess adverse perinatal outcomes associated with antenatal antiretroviral therapy (ART) regimens.
Design: Systematic review and network meta-analysis of randomized controlled trials (RCTS).
Methods: We conducted a systematic literature review by searching PubMed, CINAHL, Global Health, EMBASE, and the Cochrane Central Register of Controlled Trials and four clinical trial databases from 1 January 1980 to 28 April 2018. We included RCTs of antenatal ART regimens in HIV-positive pregnant women, which assessed preterm birth (PTB), spontaneous preterm birth (sPTB), very preterm birth (VPTB), low birthweight (LBW), very low birthweight (VLBW), small-for-gestational-age (SGA), neonatal death (NND), and mother-to-child-transmission. We used random-effects network meta-analysis models to calculate relative risks for treatment comparisons and the hierarchy of treatments.
Results: Of 83 260 citations identified, 10 manuscripts were included, assessing 6285 women. Compared with zidovudine (ZDV) monotherapy, we found a higher risk of LBW after exposure to zidovudine/lamivudine/efavirenz (ZDV/3TC/EFV; relative risk 1.61; 95% CI 1.03–2.51), tenofovir disoproxil fumarate/emtricitabine/ritonavir-boosted lopinavir (TDF/FTC/LPV/r; 1.64; 1.18–2.29), or zidovudine/lamivudine/ritonavir-boosted lopinavir (ZDV/3TC/LPV/r; 1.87; 1.58–2.20). TDF/FTC/LPV/r carried an increased risk of VLBW, compared with ZDV monotherapy (5.40; 1.08–27.08). ZDV/3TC/LPV/r posed a higher risk of PTB than ZDV monotherapy (1.43; 1.08–1.91) and a higher risk of sPTB than zidovudine/lamivudine/abacavir (ZDV/3TC/ABC) (1.81; 1.21–2.71). LPV/r-containing regimens also carried the highest risks of VPTB, SGA and NND, although the limited data showed no significant differences.
Conclusion: Of the ART regimens assessed in RCTs in pregnancy, LPV/r-containing regimens were associated with the highest risks of adverse perinatal outcomes.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 1.0MB, Terms of use)
-
- Publisher copy:
- 10.1097/QAD.0000000000002593
Authors
- Publisher:
- Wolters Kluwer
- Journal:
- AIDS More from this journal
- Volume:
- 34
- Issue:
- 11
- Pages:
- 1643-1656
- Publication date:
- 2020-07-21
- Acceptance date:
- 2020-05-21
- DOI:
- EISSN:
-
1473-5571
- ISSN:
-
0269-9370
- Language:
-
English
- Keywords:
- Pubs id:
-
1120366
- Local pid:
-
pubs:1120366
- Deposit date:
-
2020-07-19
- ARK identifier:
Terms of use
- Copyright holder:
- Wolters Kluwer Health, Inc.
- Copyright date:
- 2020
- Rights statement:
- Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
- Notes:
- This is the accepted manuscript version of the article. The final published version is available from Wolters Kluwer at https://dx.doi.org/10.1097/QAD.0000000000002593
If you are the owner of this record, you can report an update to it here: Report update to this record